Home » K-V PHARMACEUTICAL 'HOLD,' TARGET PRICE REDUCED
K-V PHARMACEUTICAL 'HOLD,' TARGET PRICE REDUCED
Analysts at Deutsche Bank Securities maintain their "hold" rating on K-V Pharmaceutical. The target price has been reduced from $26 to $20.
Newratings
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May